Daily News Podcast

Valsartan cancer risk is low

Publish date: July 31, 2018

 

The FDA says that cancer risk associated with NDMA contained in impure valsartan is definitely real, but it is very low. Also today, drinking during pregnancy could impact cognition, sexual function counseling should start early, and those with HIV develop more frailty. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Telemedicine payment expansion?
MDedge Endocrinology
Most transgender teens not willing to delay hormone therapy to preserve fertility
MDedge Endocrinology
Bundle pay plan didn’t save money
MDedge Endocrinology
Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Endocrinology
Is fibromyalgia one disorder – or two?
MDedge Endocrinology
Is fish oil’s heart benefit a fish tale?
MDedge Endocrinology
Blood pressure meds cut cognitive impairment risk
MDedge Endocrinology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Endocrinology
CTCs linked to late recurrence in HER2–, HR+ breast cancer
MDedge Endocrinology
Free skin cancer screening highlights need
MDedge Endocrinology